The Food and Drug Administration (FDA) has granted approval for leucovorin, a medication used to treat certain cancers, for use in a clinical trial focused on autism spectrum disorder. The trial, conducted by researchers at the University of California, has examined the potential benefits of a newly formulated vitamin supplement in managing symptoms associated with the condition. While the mechanism of action remains unclear, the FDA acknowledges potential benefits for individuals experiencing behavioral challenges. The approval marks a significant step in exploring vitamin supplementation as a potential therapeutic intervention for autism, though further research is required to determine efficacy and safety.
Credits: Latest News from Science Magazine
